# exorien-melio

Analyses and figures for the manuscript: 

> # The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitors
> ## Caroline E. Wheeler&, Samuel S. Coleman&, IV, Rebecca Hoyd, Louis Denko, Carlos H.F. Chan, Michelle L. Churchman, Nicholas Denko, Rebecca D. Dodd, Islam Eljilany, Sheetal Hardikar, Marium Husain, Alexandra P. Ikeguchi, Ning Jin, Qin Ma, Martin D. McCarter, Afaf E.G. Osman, Lary A. Robinson, Eric A. Singer, Gabriel Tinoco, Cornelia M. Ulrich, Yousef Zakharia, Daniel Spakowicz^, Ahmad A. Tarhini^, Aik Choon Tan^
> _bioRxiv 2023.05.24.542123; doi: https://doi.org/10.1101/2023.05.24.542123_ 

& These authors contributed equally

^ Co-corresponding authors
* Aik Choon Tan aikchoon.tan@hci.utah.edu
* Ahmad Tarhini ahmad.tarhini@moffitt.org
* Daniel Spakowicz daniel.spakowicz@osumc.edu

This is part of the exORIEN Consortium series of manuscripts, a collaboration of the [Oncology Research Information Exchange Network](https://www.oriencancer.org/)
![exORIEN Consortium log](https://github.com/spakowiczlab/exorien-melio/blob/main/doc/The-exORIEN-Consortium_logo.png)
